These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37895227)

  • 21. The Molecular Genetics of Gordon Syndrome.
    Mabillard H; Sayer JA
    Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31795491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.
    O'Reilly M; Marshall E; Macgillivray T; Mittal M; Xue W; Kenyon CJ; Brown RW
    J Am Soc Nephrol; 2006 Sep; 17(9):2402-13. PubMed ID: 16899520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
    Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
    Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
    Sohara E; Uchida S
    Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension Accompanied by Hyperaldosteronism, Hyperkalemia, and Hyperchloremic Acidosis: A Case Report and Literature Review.
    Yang Y; Ou Y; Ren Y; Tian H; Chen T
    Case Rep Endocrinol; 2020; 2020():1635413. PubMed ID: 32774943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [WNK1 and WNK4, new players in salt and water homeostasis].
    Hadchouel J; Delaloy C; Jeunemaitre X
    Med Sci (Paris); 2005 Jan; 21(1):55-60. PubMed ID: 15639021
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Mehandru SK; Haroon A; Masud A; Shah J; Kaur S; Masud A; Hossain A; Asif A; Vachharajani TJ
    Saudi J Kidney Dis Transpl; 2020; 31(5):1134-1139. PubMed ID: 33229781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and analysis of pseudohypoaldosteronism type II knock-in mice caused by a nonsense KLHL3 mutation in the Kelch domain.
    Lin CM; Sung CC; Yang SS; Chen YC; Huang SM; Lin SH
    FASEB J; 2022 Jun; 36(6):e22363. PubMed ID: 35621709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rare case of persistent hyperkalaemia.
    Lewis T; Roberts G; Zouwail S
    Ann Clin Biochem; 2021 Nov; 58(6):661-665. PubMed ID: 34159796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Familial Hyperkalemia and Hypertension with Proximal Renal Tubular Acidosis and Epileptic Seizures.
    Shirin N; Rabinowitz G; Blatt I; Karlish SJD; Farfel Z; Mayan H
    Nephron; 2024; 148(3):179-184. PubMed ID: 37666233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.
    Bergaya S; Vidal-Petiot E; Jeunemaitre X; Hadchouel J
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):39-45. PubMed ID: 22080857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gordon Syndrome: a continuing story.
    O'Shaughnessy KM
    Pediatr Nephrol; 2015 Nov; 30(11):1903-8. PubMed ID: 25503323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature review.
    Adachi M; Motegi S; Nagahara K; Ochi A; Toyoda J; Mizuno K
    Endocr J; 2023 Jul; 70(7):723-729. PubMed ID: 37081692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WNK1 and WNK4 modulate CFTR activity.
    Yang CL; Liu X; Paliege A; Zhu X; Bachmann S; Dawson DC; Ellison DH
    Biochem Biophys Res Commun; 2007 Feb; 353(3):535-40. PubMed ID: 17194447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A patient with pseudohypoaldosteronism type II complicated by congenital hypopituitarism carrying a
    Mitani M; Furuichi M; Narumi S; Hasegawa T; Chiga M; Uchida S; Sato S
    Clin Pediatr Endocrinol; 2016 Oct; 25(4):127-134. PubMed ID: 27780982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved.
    Golbang AP; Cope G; Hamad A; Murthy M; Liu CH; Cuthbert AW; O'shaughnessy KM
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1369-76. PubMed ID: 16788137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4.
    Sakoh T; Sekine A; Mori T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Hayami N; Yamanouchi M; Suwabe T; Sawa N; Ubara Y; Fujimaru T; Sohara E; Shinichi U; Hoshino J; Takaichi K
    Mol Genet Genomic Med; 2019 Jun; 7(6):e705. PubMed ID: 31044551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of SPAK inactivation on Hyperkalemic Hypertension caused by WNK1 mutations: evidence for differential roles of WNK1 and WNK4.
    Rafael C; Soukaseum C; Baudrie V; Frère P; Hadchouel J
    Sci Rep; 2018 Feb; 8(1):3249. PubMed ID: 29459793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
    Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM
    J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.